Testing effectiveness (Phase 2)UnknownNCT01790893What this trial is testingTreatment for Presumed Ocular HistoplasmosisWho this might be right forOcular Histoplasmosis John Kitchens, MD 40
Testing effectiveness (Phase 2)UnknownNCT00008307What this trial is testingCombination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Herbert Irving Comprehensive Cancer Center 52
Not applicableUnknownNCT05097664What this trial is testingOcular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in IranWho this might be right forCOVID-19Mucormycosis Isfahan University of Medical Sciences 250
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Early research (Phase 1)Study completedNCT00357292What this trial is testingOcular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy VolunteersWho this might be right forEye Infections, Bacterial Laboratoires Thea
Testing effectiveness (Phase 2)Study completedNCT00823524What this trial is testingDonor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Asan Medical Center 47
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)Study completedNCT02048007What this trial is testingMortality Reduction After Oral Azithromycin: Morbidity StudyWho this might be right forChildhood Mortality University of California, San Francisco 72,000
Post-approval studies (Phase 4)Study completedNCT03762824What this trial is testingCombined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic DiseaseWho this might be right forRheumatoid ArthritisSystemic LupusSjögren Syndrome+2 more Region Skane 300
Post-approval studies (Phase 4)WithdrawnNCT00286026What this trial is testingAzithromycin in Control of Trachoma IIWho this might be right forTrachoma University of California, San Francisco
Early research (Phase 1)Study completedNCT01158274What this trial is testingRO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01326702What this trial is testingVeliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid TumorsWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult Solid Neoplasm+35 more National Cancer Institute (NCI) 43
Early research (Phase 1)Study completedNCT00049699What this trial is testingVNP40101M in Treating Patients With Advanced or Metastatic CancerWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Vion Pharmaceuticals
Large-scale testing (Phase 3)Looking for participantsNCT06658002What this trial is testingFungal Ulcer Treatment Augmented With Natamycin and Cyclosporine AWho this might be right forFungal KeratitisCorneal Ulcer University of California, San Francisco 150
Post-approval studies (Phase 4)Study completedNCT00336531What this trial is testingEfficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell TransplantationWho this might be right forNeuroblastomaBrain TumorRetinoblastoma+2 more Samsung Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Large-scale testing (Phase 3)Study completedNCT00332293What this trial is testingAL-15469A for the Treatment of Bacterial ConjunctivitisWho this might be right forBacterial Conjunctivitis Alcon Research 695
Early research (Phase 1)Study completedNCT00077155What this trial is testingCilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+52 more National Cancer Institute (NCI) 45
Post-approval studies (Phase 4)Study completedNCT00575380What this trial is testingStudy of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract SurgeryWho this might be right forBacterial InfectionsEye InfectionsCataract Extraction Merck Sharp & Dohme LLC 116
Early research (Phase 1)Study completedNCT03926728What this trial is testingSafety and Immunogenicity of a Chlamydia Vaccine CTH522Who this might be right forTrachoma Statens Serum Institut 65